• Home >
  • Genetic Technology Alert. Genome Editing Technology for the Treatment of Blood Cancer; Genetic Risk Assessment Test for Non-Hereditary Breast Cancer; Rapid Detection of Infectious Disease through Innovations in Molecular Diagnostics

Genetic Technology Alert. Genome Editing Technology for the Treatment of Blood Cancer; Genetic Risk Assessment Test for Non-Hereditary Breast Cancer; Rapid Detection of Infectious Disease through Innovations in Molecular Diagnostics

15-May-2015  /  Research Code: D756-00-92-00-00  /  SKU: HC02716-GL-TA_19610  /  
Region: Global

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a genome editing technology for treatment of blood cancer, a genetic risk assessment test for non-hereditary breast cancer, and rapid detection of infectious disease through innovations in molecular diagnostics.

Table of Contents

Genetic Technology Alert. Genome Editing Technology for the Treatment of Blood Cancer; Genetic Risk Assessment Test for Non-Hereditary Breast Cancer; Rapid Detection of Infectious Disease through Innovations in Molecular DiagnosticsIn This Issue1. GENOME EDITING TECHNOLOGY FOR THE TREATMENT OF BLOOD CANCER2. GENETIC RISK ASSESSMENT TEST FOR NON-HEREDITARY BREAST CANCER3. RAPID DETECTION OF INFECTIOUS DISEASE THROUGH INNOVATIONS IN MOLECULAR DIAGNOSTICS4. RECENT PATENTS RELATED TO GENETIC TECHNOLOGY IN AUSTRALIA




Related Research

Recent Advances in Cancer Immunotherapy and Tumor Profiling Technologies

Release Date : 19-May-17

Region : Global

Innovations in Medical Device Technologies

Release Date : 19-May-17

Region : Global

Advancements across Health and Wellness

Release Date : 12-May-17

Region : Global

Therapeutic Breakthroughs in Multiple Sclerosis

Release Date : 12-May-17

Region : Global

Bioinformatics and Advanced Analytics Powering Drug Discovery

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.